Citrus Glow IPO Valuation: Comparing Three Pricing Models

IPO Advantages, Disadvantages, and Strategic Context

Going public has both advantages and disadvantages. The primary advantage is that it allows a firm to raise a significant amount of capital. The cost, however, is that the company may be required to cede control to investors, and there is a substantial increase in bureaucratic overhead and reporting requirements.

Dan's concerns regarding the IPO are well founded. The company's decision to retain production domestically should be made with respect to a wide range of criteria, including long-term production costs and strategic considerations, and the decision about whether to take the company public must be made within that broader context. At present, the firm has not fully considered this context, nor has it carefully weighed the impact of potentially losing control of the company. Until these factors are incorporated into the decision-making process, the company should not undertake an initial public offering (IPO).

Lisa's Corporate Value Model

The Corporate Value Model (CVM) is based on the theory that rational investors are only willing to pay fair value for an asset, and that fair value is determined as the present value of expected future cash flows. Under the CVM, future cash flows are projected using the firm's historic growth rate. The growth rate over the previous five years averaged 156.75%. The appropriate discount rate is 13.73%. The net capital investment was $2.331 million, and the free cash flow — at least as Lisa calculates it — was $50.042 million. This produces a net present value of $164 million, which over 30 million shares equates to approximately $5.45 per share.

Dan's Price-Ratio Comparables Approach

Dan's price estimate is based on applying industry-average valuation multiples to Citrus Glow's financials. The average competitor price-to-earnings (P/E) ratio is 23.6; the average price-to-book (P/B) is 8.0; the average price-to-sales is 2.86; and the average price-to-cash-flow is 14.8. Dan's resulting figures are all higher than Lisa's, ranging from $22.58 per share using the cash flow multiple to $68.34 per share using the equity (price-to-book) multiple. Dan does not provide a single official final number, as the method by which he would weight or reconcile these ratios into one stock price has not been disclosed.

Dan's approach has the benefit of providing insight into the price the market might be expected to bear for the stock. This is useful because it can help the company extract maximum value from going public. However, there are several significant downsides. First, Dan must decide which ratio is most likely to reflect how the market will actually price the stock — and the range of values produced is extremely wide, making the choice consequential and non-obvious.

Furthermore, Dan makes the rather bold assumption that the market will view Citrus Glow in the same way it views its competitors. Comparable-company analysis is only reliable when the firms being compared share similar business characteristics — including products, markets, responses to economic conditions, cost of capital, and other key attributes. The further Citrus Glow diverges from its peers on any of these dimensions, the less meaningful Dan's ratios become. Additionally, Dan's assumptions about the firm's growth prospects are arbitrary rather than grounded in an accurate assessment of the company's expected future performance.